Figure 6
From: Intracellular HMGB1 as a novel tumor suppressor of pancreatic cancer
Reduced HMGB1 expression in pancreatic tissue compared with normal adjacent tissue (NAT) in pancreatic cancer patients (A) with poor survival outcomes (B) (*P < 0.05, log-rank test).
